An ALT of 37 U/L is mildly elevated and warrants clinical evaluation based on patient context, not reassurance that it's "normal"
An ALT of 37 U/L should be considered abnormal and trigger investigation for underlying liver disease, particularly metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease, and viral hepatitis. The traditional upper limit of normal (40 U/L) is outdated and misses significant liver disease 1.
Why 37 U/L Matters
The most recent evidence demonstrates that conventional ALT thresholds are too high and were derived from populations that included individuals with occult fatty liver disease 1. Updated reference ranges from metabolically and histologically healthy populations establish the upper limit of normal as 34 U/L for males and 22 U/L for females 2. Your patient's ALT of 37 U/L exceeds these thresholds.
Key Context from Guidelines
The 2018 Gut guidelines explicitly warn that "the extent of liver blood test abnormality is not necessarily a guide to clinical significance" 1. Chronic liver diseases like NAFLD, alcohol-related liver disease, and hepatitis C frequently present with only mild ALT elevations, yet patients continue to present with end-stage liver disease that could have been prevented by earlier diagnosis 1.
Clinical Approach
Immediate Assessment Required:
Take a targeted history focusing on:
- Metabolic risk factors: BMI, waist circumference, diabetes, hypertension, dyslipidemia 3, 1
- Alcohol consumption: Quantify weekly intake in standard drinks
- Medications and supplements: Including over-the-counter drugs, vitamins, and herbal products 3
- Viral hepatitis risk factors: Blood transfusions, injection drug use, sexual history, country of origin
Initial Laboratory Workup:
Order these tests simultaneously (don't wait for repeat ALT) 3:
- Hepatitis serologies: HBsAg, anti-HBc IgM, anti-HCV, consider HCV RNA 3
- Metabolic panel: Fasting glucose, lipid panel (triglycerides, HDL cholesterol) 1
- Additional liver tests: AST, alkaline phosphatase, bilirubin, albumin, prothrombin time 3
Imaging:
- Abdominal ultrasound to assess for hepatic steatosis and exclude structural abnormalities 3
Common Pitfalls to Avoid
Do not simply repeat the ALT to "see if it normalizes" 1. This outdated approach delays diagnosis. The 2018 guidelines state that repeating tests is only justified when there's high certainty the abnormality will resolve from an identified acute insult 1. For chronic conditions like MASLD and hepatitis C, even normalized ALT doesn't exclude disease 1.
Do not dismiss this as "borderline" or "minimally elevated" 1. Research shows that ALT values as low as 10 U/L in women and 22 U/L in men predict diabetes mellitus 4, and values above these thresholds correlate with metabolic dysfunction even in the absence of overt liver disease.
Sex-Specific Considerations
If your patient is male, an ALT of 37 U/L exceeds the updated threshold of 34-36 U/L 2, 5. If female, this value is substantially elevated above the 22-28 U/L threshold 2, 5. For hepatitis B specifically, treatment guidelines use even lower thresholds: >30 U/L for males and >19 U/L for females 1.
Risk Stratification
In metabolically healthy individuals (normal BMI, no diabetes, normal lipids), the 95th percentile ALT is 32 U/L overall 5. In overweight/obese individuals, the threshold rises to 40 U/L, but this reflects disease prevalence, not health 5. Your patient's ALT of 37 U/L suggests either metabolic dysfunction or other liver pathology requiring identification.
If Metabolic Risk Factors Present:
Among individuals with ALT ≥34 U/L (males) or ≥22 U/L (females) who are metabolically healthy by histology, 72.8% of males and 55.0% of females showed hepatic steatosis 2. This underscores that your patient likely has underlying liver pathology.
Bottom Line
Proceed directly to etiologic investigation rather than observation 3, 1. The clinical context determines significance, not the absolute ALT value. Patients with chronic hepatitis C can have normal ALT yet progress to cirrhosis, while those with acute hepatitis A can have ALT >1000 U/L and fully recover 1. Your goal is to identify treatable causes of liver disease before progression to fibrosis or cirrhosis.